These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28527911)

  • 1. Cancer stem cells: at the forefront of personalized medicine and immunotherapy.
    Fiori ME; Villanova L; De Maria R
    Curr Opin Pharmacol; 2017 Aug; 35():1-11. PubMed ID: 28527911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of cancer stem cells in solid tumours. A review.
    Maccalli C; Volontè A; Cimminiello C; Parmiani G
    Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells, CD200 and immunoevasion.
    Kawasaki BT; Farrar WL
    Trends Immunol; 2008 Oct; 29(10):464-8. PubMed ID: 18775673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
    Singh D; Khan MA; Siddique HR
    Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
    Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
    Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
    Ma Y; Lv H; Xing F; Xiang W; Wu Z; Feng Q; Wang H; Yang W
    Front Med; 2024 Jun; 18(3):430-445. PubMed ID: 38600350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
    Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modelling of cancer stem cell-targeted immunotherapy.
    Sigal D; Przedborski M; Sivaloganathan D; Kohandel M
    Math Biosci; 2019 Dec; 318():108269. PubMed ID: 31622595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
    Liang ZM; Chen Y; Luo ML
    Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity in cancer stem cells and tumor evolution: Toward precision medicine.
    La Porta CAM; Zapperi S
    Semin Cancer Biol; 2017 Jun; 44():3-9. PubMed ID: 28254567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.
    Galassi C; Musella M; Manduca N; Maccafeo E; Sistigu A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure.
    Castagnoli L; De Santis F; Volpari T; Vernieri C; Tagliabue E; Di Nicola M; Pupa SM
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cancer stem cell-targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model.
    Caras IW
    Stem Cells Transl Med; 2020 Aug; 9(8):821-826. PubMed ID: 32281289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
    Donini C; Rotolo R; Proment A; Aglietta M; Sangiolo D; Leuci V
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.